Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury
22 Jun 2021 //
BUSINESSWIRE
Lineage Announces Exclusive Option Agreement With Amasa Therapeutics
17 Jun 2021 //
BUSINESSWIRE
Lineage Announces Exclusive Option Agreement With Amasa Therapeutics
16 Jun 2021 //
BUSINESSWIRE
Lineage Announces Worldwide License Agreement With Immunomic Therapeutics
19 Apr 2021 //
BUSINESSWIRE